Register for email alerts and news feeds:
This journal | BMJ Group
rss
Evidence-Based Mental Health 2006;9:41; doi:10.1136/ebmh.9.2.41
Copyright © 2006 by BMJ Publishing Group Ltd, Royal College of Psychiatrists, & British Psychological Society.

Therapeutics

Aripiprazole reduces acute mania compared with haloperidol in bipolar I disorder and causes fewer adverse effects

Vieta E, Bourin M, Sanchez R, et al. Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial. Br J Psychiatry 2005;187:235–42.[Abstract/Free Full Text]

Q Is three months of treatment with aripiprazole more effective than haloperidol for people with bipolar disorder having an acute or mixed episode?

Key Words: aripiprazole • haloperidol • bipolar disorder

The first 150 words of the full text of this article appear below.

METHODS

Formula Design: Multicentre randomised controlled trial.

Formula Allocation: Unclear.

Formula Blinding: Double blind.

Formula Follow up period: Twelve weeks.

Formula Setting: Seventy six international centres; time period not reported.

Formula Patients: 347 people aged 18–65 years with non-rapid cycling bipolar I disorder (DSM-IV) currently experiencing a recent onset acute or mixed episode, and with Young Mania Rating Score (YMRS) >=20. Exclusions: unresponsiveness to antipsychotics, recent treatment with lithium, divalproate, or long acting antipsychotic, substance misuse, high suicide risk, use of psychotropic medications (except benzodiazepines) or fluoxetine treatment in the prior month, previous enrolment in an aripiprazole trial.

Formula Intervention: Aripiprazole (15–30 mg daily) or haloperidol (10–15 mg daily) for 12 weeks (after a 1–3 day washout of current medication). Participants who did not tolerate study medication, had a Clinical Global Impression - Bipolar disorder mania severity score of >=4, or a Montgomery-Åsberg Depression Rating Scale score >=18 at three weeks were removed from the trial.

Formula Outcomes: Response . . . [Full text of this article]

Franca Centorrino, MD

Assistant Professor of Psychiatry, Harvard Medical School and Director,
Schizophrenia and Bipolar Disorder Clinic, McLean Hospital, Belmont,
MA USA


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Online Education

Psychiatry CPD/CME from The Royal College of Psychiatrists

Professional Development from The British Psychological Society